thromboplastin and Acquired-Immunodeficiency-Syndrome

thromboplastin has been researched along with Acquired-Immunodeficiency-Syndrome* in 7 studies

Other Studies

7 other study(ies) available for thromboplastin and Acquired-Immunodeficiency-Syndrome

ArticleYear
The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.
    The Journal of clinical investigation, 1997, Apr-01, Volume: 99, Issue:7

    The plasma membrane remodeling, including the early transverse redistribution of phosphatidylserine, is a general feature occurring in cells in which a death program has been induced. In most cases, studies of this kind have focused mainly on cells. In this study, we report a clear correlation between the degree of apoptosis induced by a variety of agents in several types of cultured cells and the amount of shed membrane microparticles captured in the corresponding supernatants by insolubilized annexin V, a protein showing a strong affinity for phosphatidylserine. Such particles carry membrane antigens specific of the cells they stem from, and through which capture is also feasible. Homologous circulating microparticles were captured in peripheral blood from individuals with HIV-1 infection. A substantial proportion bore CD4 antigen. In some cases, CD4+ particles could be detected even in the absence of circulating CD4+ T cells, testifying to the presence of such resident cells in lymphoid tissues. These results suggest that shed membrane particles are one of the hallmarks of programmed cell death, of particular interest when the corresponding cells are hardly accessible.

    Topics: Acquired Immunodeficiency Syndrome; Antigens, Surface; Apoptosis; Cells, Cultured; DNA Fragmentation; HIV-1; Humans; Thromboplastin

1997
Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.
    The American journal of pathology, 1994, Volume: 144, Issue:1

    We studied seven cases of Kaposi's sarcomas (KS) obtained from patients with AIDS and one KS from a patient without HIV infection. Antigen expression was studied by immunocytochemistry and mRNA expression by in situ hybridisation. The markers tested were endothelial leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. In all tumors (AIDS and non-AIDS associated) these markers reacted positive, indicating transcription and translation of these genes in KS. The synthesis and expression of tissue factor and thrombomodulin suggests that KS is a tumor that has tissue factor-mediated thrombin formation under the control of thrombomodulin. The expression of thrombomodulin and endothelial leukocyte adhesion molecule-1 provides evidence for the vascular origin of KS.

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Blood Vessels; Cell Adhesion; Cell Adhesion Molecules; E-Selectin; Humans; Immunohistochemistry; In Situ Hybridization; Sarcoma, Kaposi; Thrombomodulin; Thromboplastin

1994
Dysregulation of cytokine expression in monocytes from HIV-positive individuals.
    Journal of leukocyte biology, 1994, Volume: 56, Issue:3

    Because HIV may alter the production of inflammatory factors produced by monocytes, the expression of tumor necrosis factor alpha (TNF-alpha), tissue factor (TF), interleukin (IL)-1 beta, and IL-6 was evaluated in 47 HIV-seropositive persons and seronegative control subjects. RNA was extracted from freshly isolated lipopolysaccharide (LPS)-stimulated or unstimulated monocytes. Cytokine and TF expression was quantitated by dot blot hybridization or a reverse transcription polymerase chain reaction (RT-PCR). A significant depression of TF mRNA was observed in LPS-stimulated monocytes (66% less in AIDS, 20% less in AIDS-related complex (ARC), and 0% less in asymptomatic patients), whereas normal responses were observed for TNF-alpha, IL-1 beta, and IL-6. When constitutive expression was measured in unstimulated monocytes by RT-PCR, a differential pattern was also observed. TNF-alpha and IL-1 beta were positive in 85% of asymptomatic persons, compared with only 27% of ARC and 42% of AIDS patients. Expression of IL-6 was observed in lower proportions, 27-30%, with no significant differences among disease states. All samples were negative for TF. Thus, the regulation of inflammatory molecules is differentially altered in individuals with HIV infection. TF is preferentially down-regulated, compared with TNF-alpha, IL-1 beta, and IL-6, in LPS-stimulated monocytes as patients progress to AIDS. TNF-alpha and IL-1 beta are preferentially up-regulated, compared with IL-6 and TF, in unstimulated monocytes in asymptomatic persons, with a loss of up-regulation as patients progress to AIDS.

    Topics: Acquired Immunodeficiency Syndrome; Cell Separation; Cytokines; Gene Expression Regulation, Viral; Humans; Interleukin-1; Interleukin-6; Lipopolysaccharides; Monocytes; Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Tumor Necrosis Factor-alpha; Up-Regulation

1994
A selective defect in tissue factor mRNA expression in monocytes from AIDS patients.
    Clinical immunology and immunopathology, 1990, Volume: 54, Issue:1

    Expression of tumor necrosis factor (TNF alpha), tissue factor (TF), and interleukin 1-beta (IL-1 beta) mRNA was evaluated in monocytes isolated from patients infected with human immunodeficiency virus (HIV). There was a significant depression (66%) of the induced level of TF mRNA expression in response to lipopolysaccharide. Conversely, the response of TNF alpha and IL-1 beta, following LPS induction, was "normal." TF mRNA reduction was also observed to a lesser degree in AIDS-related complex patients (20%) but not in asymptomatic seropositives. TF is necessary for initiation of the coagulation protease cascade, leading to thrombin production and fibrin deposition, which play a role in inflammatory responses. Its selective reduction may be a factor in the diminished resistance to secondary infections observed in AIDS. Further, since the TF defect increases as patients progress toward AIDS, it may serve as a marker for disease progression.

    Topics: Acquired Immunodeficiency Syndrome; Adult; Blood Coagulation; Humans; Hypersensitivity, Delayed; Interleukin-1; Lipopolysaccharides; Male; Monocytes; RNA, Messenger; Thromboplastin; Tumor Necrosis Factor-alpha

1990
Local activation of the coagulation and fibrinolysis systems in lung disease.
    Thrombosis research, 1990, Mar-15, Volume: 57, Issue:6

    Extravascular coagulation and fibrinolysis is an integral part of inflammatory reactions. Disordered expression of procoagulant and profibrinolytic factors by mononuclear phagocytes of the lung (i.e. lung alveolar macrophages (LAM) and interstitial macrophages) may have important bearings on inflammatory lung tissue destruction and repair. Based on this hypothesis we have measured the presence of trigger molecules and activation products of the coagulation and fibrinolytic system in cell-free bronchoalveolar lavage fluid and in bronchoalveolar cells. Patient groups with chronic obstructive disease (COLD) (n = 76), idiopathic pulmonary fibrosis (IPF) (n = 29), sarcoidosis (n = 22), lung cancer (n = 36), pneumonia (n = 39), acquired immunodeficiency syndrome (AIDS) (n = 17) and a control group (n = 60) were studied by bronchoalveolar lavage (BAL). In all patient groups tissue thromboplastin (TPL) and fibrinopeptide A (FPA) were significantly increased compared to controls. Plasminogen activator (PA) activity was significantly lower in patients than in normals, and usually associated with high levels of antifibrinolytic activity. The level of PA inhibitor (PAI-2) was not significantly higher in any patient group compared to controls. The sensitivity of the method for fibrin degradation products (FDP) analysis was not high enough to detect FDP in BAL fluid of control individuals, whereas such products could be demonstrated in 25-53% of patients in various categories. We conclude that disordered expression of procoagulant and plasminogen activator activities in bronchoalveolar lavage fluid may reflect a milieu that favours accumulation of fibrin in inflammatory lung tissue and form the basis for the development of pulmonary fibrosis.

    Topics: Acquired Immunodeficiency Syndrome; Blood Coagulation; Bronchoalveolar Lavage Fluid; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Fibrinopeptide A; Humans; Inflammation; Lung Diseases; Plasminogen Inactivators; Pulmonary Fibrosis; Thromboplastin

1990
[2 SIMPLE TESTS AS AIDS IN DETECTING AN UNUSUAL COAGULATION DISORDER].
    Folia haematologica (Leipzig, Germany : 1928), 1963, Volume: 81

    Topics: Acquired Immunodeficiency Syndrome; Blood Coagulation Disorders; Humans; Hypersensitivity; Lupus Erythematosus, Systemic; Neutrophils; Prothrombin Time; Thromboplastin

1963
THE THROMBOPLASTIN generation test; aids in the study of coagulation defects. II.
    The Ohio State medical journal, 1957, Volume: 53, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Blood Coagulation; Blood Coagulation Disorders; Humans; Thromboplastin

1957